Bruce Strober, MD, PhD, FAAD

To watch the video series component of this episode, click here. 

5:11 Classifying the Severity of Plaque Psoriasis

8:30 Laboratory Tests for Systemic Therapy

13:22 Monitoring Systemic Therapy in Plaque Psoriasis

16:50 New Oral Systemic Therapies for Plaque Psoriasis

28:03 Long-term Safety Data of Deucravacitinib

34:52 Selecting the Right Treatment for the Right Patient


Podcasts

A panel of dermatologists have a comprehensive discussion on exciting developments in the treatment of plaque psoriasis, focusing on treatment approaches, patient monitoring strategies, and recent clinical trial data.

Beyond the Surface: Monitoring your Patients with Moderate to Severe Plaque Psoriasis

Clinical insights on long-term safety data for deucravacitinib and selecting the right treatment for the right patient.

Deucravacitinib Safety Data and Treatment Selection Considerations

0:05 Long-term Safety Data of Deucravacitinib

6:55 Selecting the Right Treatment for the Right Patient


Videos

Bruce Strober, MD, PhD, and Linda Stein Gold, MD, provide clinical insights on long-term safety data for deucravacitinib and selecting the right treatment for the right patient.

Dermatologists have a comprehensive discussion on systemic therapies for the treatment of plaque psoriasis.

Systemic Therapies for Plaque Psoriasis

0:05 Monitoring Systemic Therapy in Plaque Psoriasis

3:34 New Oral Systemic Therapies for Plaque Psoriasis

Dermatologists have a comprehensive discussion on systemic therapies for the treatment of plaque psoriasis, covering monitoring practices, and long term efficacy data  for novel oral agent deucravacitinib.

Linda Stein Gold, MD, and Bruce Strober, MD PhD, discuss classification and monitoring practices for patients with plaque psoriasis.

Plaque Psoriasis: Comorbidities, Classification, and Testing Practices

5:16 Classifying the Severity of Plaque Psoriasis

8:35 Laboratory Tests for Systemic Therapy

Bruce Strober, MD, PhD, FAAD

Articles